Literature DB >> 12202209

The carboxyl segment of the mumps virus V protein associates with Stat proteins in vitro via a tryptophan-rich motif.

Machiko Nishio1, Dominique Garcin, Viviane Simonet, Daniel Kolakofsky.   

Abstract

Viruses of the Paramyxovirinae, similar to other viruses, have evolved specific proteins that interdict IFN action as part of a general strategy to counteract host innate immunity. In many (but not all) cases, this interdiction is accompanied by a lowering of the intracellular levels of the STAT proteins. Among rubulaviruses, there is a notable variation in how they interfere with IFN action. Whereas SV41, SV5, and MuV all act by lowering Stat1, hPIV2 acts by lowering Stat2. Here, we show that the mumps and hPIV2 V proteins both form a complex with several Stat proteins in a mixed-extract assay. This suggests that the specific degradation of these Stat proteins is not determined by complex formation, but presumably at some later stage of the degradation pathway. V/Stat complex formation requires a specific carboxyl segment of V. However, a previously unrecognized trp-rich motif, rather than the Zn(++)-binding cys-cluster of this segment, appears to be required for V/Stat interaction. The C protein of Sendai (respiro-) virus, another P gene encoded protein, also forms a complex with Stat1, and prebinding of MuV V to Stat1 prevents the subsequent binding of SeV C. Our results suggest that rubulavirus V proteins may be related to both the C and the V proteins of respiroviruses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202209     DOI: 10.1006/viro.2002.1509

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  40 in total

1.  Identification of human parainfluenza virus type 2 (HPIV-2) V protein amino acid residues that reduce binding of V to MDA5 and attenuate HPIV-2 replication in nonhuman primates.

Authors:  Anne Schaap-Nutt; Caraline Higgins; Emerito Amaro-Carambot; Sheila M Nolan; Christopher D'Angelo; Brian R Murphy; Peter L Collins; Alexander C Schmidt
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

2.  Function of small hydrophobic proteins of paramyxovirus.

Authors:  Rebecca L Wilson; Sandra M Fuentes; Ping Wang; Erica C Taddeo; Alicia Klatt; Andrew J Henderson; Biao He
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Immunogenicity of novel mumps vaccine candidates generated by genetic modification.

Authors:  Pei Xu; Zhenhai Chen; Shannon Phan; Adrian Pickar; Biao He
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

Review 4.  Paramyxovirus disruption of interferon signal transduction: STATus report.

Authors:  Aparna Ramachandran; Curt M Horvath
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

Review 5.  Paramyxovirus evasion of innate immunity: Diverse strategies for common targets.

Authors:  Michelle D Audsley; Gregory W Moseley
Journal:  World J Virol       Date:  2013-05-12

6.  Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys.

Authors:  Anne Schaap-Nutt; Margaret A Scull; Alexander C Schmidt; Brian R Murphy; Raymond J Pickles
Journal:  Vaccine       Date:  2010-02-20       Impact factor: 3.641

7.  Interaction of mumps virus V protein variants with STAT1-STAT2 heterodimer: experimental and theoretical studies.

Authors:  Nora H Rosas-Murrieta; Irma Herrera-Camacho; Helen Palma-Ocampo; Gerardo Santos-López; Julio Reyes-Leyva
Journal:  Virol J       Date:  2010-10-11       Impact factor: 4.099

8.  Rab27a facilitates human parainfluenza virus type 2 growth by promoting cell surface transport of envelope proteins.

Authors:  Keisuke Ohta; Yusuke Matsumoto; Machiko Nishio
Journal:  Med Microbiol Immunol       Date:  2018-01-27       Impact factor: 3.402

9.  Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates.

Authors:  Anne Schaap-Nutt; Christopher D'Angelo; Margaret A Scull; Emerito Amaro-Carambot; Machiko Nishio; Raymond J Pickles; Peter L Collins; Brian R Murphy; Alexander C Schmidt
Journal:  Virology       Date:  2009-12-07       Impact factor: 3.616

10.  Mumps virus Enders strain is sensitive to interferon (IFN) despite encoding a functional IFN antagonist.

Authors:  D F Young; M C Galiano; K Lemon; Y-H Chen; J Andrejeva; W P Duprex; B K Rima; R E Randall
Journal:  J Gen Virol       Date:  2009-07-22       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.